Navigation Links
Diplomat Specialty Pharmacy Expands National Hemophilia & IVIG Program

SWARTZ CREEK, Mich., Feb. 4 /PRNewswire/ -- Diplomat Specialty Pharmacy is pleased to announce two new "Navigator" initiatives (disease management programs). As of January 2009, DSP launched both a Hemophilia and IVIG Navigator Program. In addition, Scott Reed has joined Diplomat as National Sales Manager for both programs. Reed is a graduate of Indiana University and has over 18 years of pharmaceutical sales experience. Most recently Reed was a Hematology Account Executive with Bayer HealthCare, prior to that he was a Sales Manager with ZLB (CSL Behring). Reed will report directly to Mark Neville, Vice President of Sales and Marketing.

Reed will team with Diplomat's Director of Pharmacy Development and Operations, Rinku A. Patel, RPh, PharmD. Patel will lead the development of program infrastructure to support Diplomat's Hemophilia and IVIG Navigator programs.

"Hemophilia patients require a very high touch patient care model and Diplomat's services are a perfect fit for these patients," stated Patel. "Diplomat's Navigator Programs, through direct patient care and coordination with providers, improve access, tolerance, and compliance resulting in enhanced clinical and economic outcomes for patients with bleeding disorders."

"Diplomat Specialty Pharmacy is very excited to welcome Scott to our team," said Neville. "Under Dr. Patel's clinical expertise, Scott will lead our efforts in launching Diplomat's national program that will provide the highest level of clinical care to patients with bleeding disorders and IVIG needs."

"After spending many years in the hemophilia marketplace, I am happy to join the team at Diplomat Specialty Pharmacy," said Reed. "A hemophilia and IVIG program can improve medication adherence, control costs and improve quality of life. Diplomat's Disease Management programs are the most comprehensive and innovative programs available. I look forward to being a part of the great things that are happening at Diplomat Specialty Pharmacy."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation's largest independently held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

    For more information contact:
    Kathy Karns

SOURCE Diplomat Specialty Pharmacy
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
2. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
3. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
4. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
5. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
6. Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations
7. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
10. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
11. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
Post Your Comments:
(Date:10/12/2017)... , ... October 12, 2017 ... ... has launched Rosalind™, the first-ever genomics analysis platform specifically designed for life ... Named in honor of pioneering researcher Rosalind Franklin, who made a major ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ComplianceOnline’s Medical Device ... on 7th and 8th June 2018 in San Francisco, CA. The Summit brings together ... as several distinguished CEOs, board directors and government officials from around the world to ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
Breaking Biology Technology:
(Date:5/6/2017)... RAM Group , Singaporean based ... in biometric authentication based on a novel  ... to perform biometric authentication. These new sensors are based on ... Ram Group and its partners. This sensor will have ... and security. Ram Group is a next generation ...
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at  under ... . 2016 Year Highlights: ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Biology News(10 mins):